---
title: "Fosun Pharmaceutical Gets Drug Registration for Antibiotic, Hypertension Medications"
date: "2025-02-11 10:54:27"
summary: "Shanghai Fosun Pharmaceutical obtained registrations for two drugs from China's food and drug administrator, according to a Monday filing with the Shanghai bourse. Polymyxin B sulfate for injection is intended for treating gram-negative bacterial infections resistant to conventional therapy, while labetalol hydrochloride injection is used to treat severe hypertension and..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Shanghai Fosun Pharmaceutical obtained registrations for two drugs from China's food and drug administrator, according to a Monday filing with the Shanghai bourse.

Polymyxin B sulfate for injection is intended for treating gram-negative bacterial infections resistant to conventional therapy, while labetalol hydrochloride injection is used to treat severe hypertension and for controlling hypotension during anesthesia.

Shares of the pharmaceutical company were down 1% in recent trade.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250210:G2465967:0/)
